Broadening the factor V Leiden paradox: Pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum

Blood

Volumn 120, Issue 5, 2012, Pages 933-946

  Van Langevelde, Kirsten ^a   Flinterman, Linda E ^a   Vlieg, Astrid Van Hylckama ^a   Rosendaal, Frits R ^a   Cannegieter, Suzanne C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

ALCOHOL CONSUMPTION; BLOOD GROUP O; BODY HEIGHT; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROHN DISEASE; DEEP VEIN THROMBOSIS; ETHNICITY; EXERCISE; GENE MUTATION; GROUPS BY AGE; HUMAN; HYPERTHYROIDISM; IMMOBILIZATION; KIDNEY DISEASE; LEG INJURY; LUNG EMBOLISM; NEOPLASM; OBESITY; PNEUMONIA; POPULATION BASED CASE CONTROL STUDY; POSTOPERATIVE THROMBOSIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; SMOKING; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VENOUS STASIS;

EID: 84864555828     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-407551     Document Type: Review

References (80)

1. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692-699. (Pubitemid 46563566)
2. Desmarais S, de Moerloose P, Reber G, et al. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet. 1996;347(9012):1374-1375. (Pubitemid 26147935)
3. van Stralen KJ, Doggen CJM, Bezemer ID, et al. Mechanisms of the factor V Leiden paradox. Arterioscler Thromb Vasc Biol. 2008;28(10):1872-1877.
4. Manten B, Westendorp RG, Koster T, et al. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost. 1996;76(4):510-513. (Pubitemid 26372002)
5. Arsov T, Miladinova D, Spiroski M. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Croat Med J. 2006;47(3):433-439.
6. Baglin TP, Brown K, Williamson D, et al. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population. Thromb Haemost. 1997;77(6):1219.
7. Martinelli I, Cattaneo M, Panzeri D, et al. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost. 1997;77(3):440-443. (Pubitemid 27121005)
8. Ordonez AJ, Carreira JM, Alvarez CR, et al. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A. Thromb Haemost. 2000;83(2):352-354. (Pubitemid 30093248)
9. Boyanovsky B, Russeva M, Ganev V, et al. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Blood Coagul Fibrinolysis. 2001;12(8):639-642. (Pubitemid 33139682)
10. Margaglione M, Brancaccio V, De Lucia D, et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest. 2000;118(5):1405-1411.
11. de Moerloose P, Reber G, Perrier A, et al. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol. 2000; 110(1):125-129. (Pubitemid 30625600)
12. Emmerich J, Rosendaal FR, Cattaneo M, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism: pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost. 2001; 86(3):809-816. (Pubitemid 32834190)
13. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007;110(3):908-912. (Pubitemid 47267428)
14. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005;2005:1-12.
15. Kniffin WD Jr, Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154(8):861-866. (Pubitemid 24135768)
16. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991; 151(5):933-938.
17. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPIGETBP Study Group: Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83(5):657-660.
18. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-593. (Pubitemid 28144815)
19. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010; 121(17):1896-1903.
20. Severinsen MT, Johnsen SP, Tjonneland A, et al. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med. 2010;21(4): 268-272.
21. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123(suppl 4):S11-S17.
22. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000; 85(11):1334-1337. (Pubitemid 30314667)
23. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998;128(9):737-740. (Pubitemid 28204865)
24. Lutsey PL, Cushman M, Heckbert SR, et al. Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height: the Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost. 2011;106(1):113-120.
25. Braekkan SK, Borch KH, Mathiesen EB, et al. Body height and risk of venous thromboembolism: the Tromso Study. Am J Epidemiol. 2010; 171(10):1109-1115.
26. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978-980. (Pubitemid 41297761)
27. Pomp ER, le Cessie S, Rosendaal FR, et al. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139(2):289-296. (Pubitemid 47493087)
28. Beam DM, Courtney DM, Kabrhel C, et al. Risk of thromboembolism varies, depending on category of immobility in outpatients. Ann Emerg Med. 2009;54(2):147-152.
29. Cannegieter SC, Doggen CJM, van Houwelingen HC, et al. Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med. 2006;3(8):e307.
30. Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583.
31. van Stralen KJ, Rosendaal FR, Doggen CJM. Minor injuries as a risk factor for venous thrombosis. Arch Intern Med. 2008;168(1):21-26.
32. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921.
33. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995;346(8990):1575-1582.
34. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183-1188. (Pubitemid 27464583)
35. Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637. (Pubitemid 351404930)
36. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005; 143(10):697-706.
37. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162(10):975-982. (Pubitemid 41619468)
38. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182-1189. (Pubitemid 34522408)
39. Sidney S, Petitti DB, Soff GA, et al. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception. 2004;70(1):3-10. (Pubitemid 38781972)
40. van Stralen KJ, le Cessie S, Rosendaal FR, et al. Regular sports activities decrease the risk of venous thrombosis. J Thromb Haemost. 2007;5(11): 2186-2192. (Pubitemid 47617869)
41. Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117(1): 93-102. (Pubitemid 350301144)
42. Pomp ER, Rosendaal FR, Doggen CJM. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol. 2008;83(2):97-102.
43. Pomp ER, Rosendaal FR, Doggen CJM. Alcohol consumption is associated with a decreased risk of venous thrombosis. Thromb Haemost. 2008; 99(1):59-63.
44. Blom JW, Doggen CJM, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715-722. (Pubitemid 40216041)
45. Tillie-Leblond I, Marquette CH, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med. 2006;144(6):390-396. (Pubitemid 46768160)
46. Stein PD, Beemath A, Meyers FA, et al. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med (Hagerstown). 2007;8(4):253-257. (Pubitemid 46586662)
47. Baum G, Fisher F. The relationship of fatal pulmonary insufficiency with cor pulmonale, rightsided mural thrombi and pulmonary emboli: a preliminary report. Am J Med Sci. 1960;240:609-612.
48. Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010; 25(4):253-260.
49. Stein PD, Beemath A, Meyers FA, et al. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med. 2006;119(10):897.e7-e11.
50. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657-663.
51. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103(9):2272-2280.
52. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53(4):542-548. (Pubitemid 38372979)
53. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85(3): 430-434. (Pubitemid 32233013)
54. van Zaane B, Squizzato A, Huijgen R, et al. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood. 2010;115(22):4344-4349.
55. Jick H, Slone D, Westerholm B, et al. Venous thromboembolic disease and ABO blood type: a cooperative study. Lancet. 1969;1(7594):539-542.
56. Morelli VM, De Visser MC, Vos HL, et al. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost. 2005;3(1):183-185. (Pubitemid 41647137)
57. Koster T, Blann AD, Briet E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345(8943):152-155.
58. Wautrecht JC, Galle C, Motte S, et al. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost. 1998;79(3):688-689. (Pubitemid 28120810)
59. Mercier B, Oger E, Le Gal G, et al. Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost. 2005;93(2):388-389. (Pubitemid 40253751)
60. Schleef M, Strobel E, Dick A, et al. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol. 2005;128(1):100-107.
61. Wiggins KL, Smith NL, Glazer NL, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost. 2009;7(2):263-269.
62. Talbot S, Wakley EJ, Langman MJ. A19 A29 B, and O blood-groups, Lewis blood-groups, and serum triglyceride and cholesterol concentrations in patients with venous thromboembolic disease. Lancet. 1972;1(7761):1152-1154.
63. Gonzalez Ordonez AJ, Medina Rodriguez JM, Martin L, et al. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagul Fibrinolysis. 1999;10(5):303-307. (Pubitemid 29382672)
64. Tirado I, Mateo J, Soria JM, et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost. 2005;93(3):468-474. (Pubitemid 40392534)
65. Ohira T, Cushman M, Tsai MY, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost. 2007;5(7):1455-1461. (Pubitemid 46965375)
66. Larsen TB, Johnsen SP, Gislum M, et al. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium: a population-based, nested case-control study. J Thromb Haemost. 2005;3(2):300-304. (Pubitemid 41623618)
67. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88(10):3698-3703. (Pubitemid 26383091)
68. Okumus G, Kiyan E, Arseven O, et al. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost. 2008;14(2):168-173. (Pubitemid 351364016)
69. Weischer M, Juul K, Zacho J, et al. Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population. Atherosclerosis. 2010;208(2):480-483.
70. Jun ZJ, Ping T, Lei Y, et al. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol. 2006;28(2):111-116.
71. Castoldi E, Rosing J. APC resistance: biological basis and acquired influences. J Thromb Haemost. 2010;8(3):445-453.
72. Lijfering WM, Christiansen SC, Naess IA et al. The risk of venous thrombosis related to increase in body mass index is mediated by factor VIII induced APC resistance [abstract]. Blood. 2009; 114:3985. Abstract 453.
73. Parker AC, Mundada LV, Schmaier AH, et al. Factor V Leiden inhibits fibrinolysis in vivo. Circulation. 2004;110(23):3594-3598. (Pubitemid 39612576)
74. Bajzar L, Kalafatis M, Simioni P, et al. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V Leiden. J Biol Chem. 1996;271(38):22949-22952. (Pubitemid 26314721)
75. de Boer JD, Majoor CJ, van 't Veer C, et al. Asthma and coagulation. Blood. 2012;119(14): 3236-3244.
76. Ribeiro DD, Lijfering WM, van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Pneumonia and risk of venous thrombosis: results from the MEGA study [published online ahead of print April 7, 2012]. J Thromb Haemost. doi:10.1111/j.1538-7836.2012.04732.x.
77. Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367(9516):1075-1079.
78. Moser KM, Fedullo PF, LitteJohn JK, et al. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994; 271(3):223-225. (Pubitemid 24041261)
79. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost. 2002;88(3):407-414. (Pubitemid 35021597)
80. Baglin T, Douketis J, Tosetto A, et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost. 2010;8(11):2436-2442.